Navigation Links
Doctor at Cincinnati Children's receives prestigious NIH MERIT Award

Marc E. Rothenberg, M.D., Ph.D., director of the Division of Allergy and Immunology at Cincinnati Children's, has received an NIH MERIT Award to extend funding of his long-standing investigation into "Regulation of Gastrointestinal Eosinophils."

Dr. Rothenberg received the award from the National Institute of Allergy and Infectious Diseases (NIAID) due to his "stellar record of research accomplishment."

Eosinophilic disorders occur when the body's immune system mistakenly treats nutritious food as a dangerous foreign invader. As a result, the body produces an excess of eosinophils, a type of white blood cell that can cause chronic inflammation and tissue damage.

Dr. Rothenberg's studies are aimed at increasing understanding of the properties of gastrointestinal eosinophils, their involvement in immune responses, and viable methods to block their role in the cause of disease.

The MERIT Award gives investigators the opportunity to obtain up to 10 years of research support in two five-year segments, thereby relieving awardees of the need to prepare frequent renewal applications.

"The backing of our research program through this award will provide us an extraordinary opportunity to enhance our long-term, in-depth pursuit of developing the best therapy and eventual cure for eosinophilic gastrointestinal diseases," says Dr. Rothenberg. "With the MERIT Award extending these studies for another ten years, I am hopeful that truly meaningful research will be accelerated."

MERIT Awards are offered to a limited number of investigators, with the NIAID selecting approximately 12 annually from its entire research portfolio of hundreds of grants.

"This award is a tribute to the wonderful people associated with my laboratory and research program over the past ten years," says Dr. Rothenberg. "These diverse researchers are creative and highly interactive, resulting in a productive work environment that, through this award, has been recognized as such by the NIH."


Contact: Kate Setter
Cincinnati Children's Hospital Medical Center

Related medicine news :

1. Wiser Pregnancy Reveals What Doctors Did In Situations Like Yours
2. Consult A Doctor Closes $5 Million VC Round
3. Helmets must be part of skiing and snowboarding culture, doctors urge
4. The Doctor Is in...But Where Is the Tax Advisor?
5. Doctors Have Many Ways to Say No
6. Doctors Working Less, Earning Less
7. Doctors Share Longevity Secrets on CBS Broadcasts
8. Shortage of Black Doctors Rooted in Social, Economic Ills
9. Doctors Practice Medicine in Fear, New Study Finds
10. Doctors Applaud House Vote to Remove Anti-Trust Exemption for Health Insurers
11. Doctor Joseph Racanelli is Helping Christina Get Back Her Shape After Brutal Attack
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... 1980s we have seen vast improvements in scientific research and discoveries, leading us ... providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition ...
(Date:12/1/2015)... ... December 01, 2015 , ... The ... been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable ... Meeting from November 29 to December 4, 2015. , MED-TAB is expected ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... San Francisco, CA (PRWEB) , ... December 01, ... ... The Behavioral Health Center of Excellence (BHCOE) today announced that the organization has ... based in San Francisco, with a Distinguished Award. The award celebrates exceptional special ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, ... in the United States. Clarity is a Superior Dual Wavelength Platform which combines ... single platform that is easy to own and operate. , For over a ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical ... that it has reached its enrollment target of 400 ... trial of aldoxorubicin in patients with previously treated soft ... in Q1 2016. The Phase 3 trial is a randomized, ... from the FDA at 79 sites in ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
(Date:12/1/2015)... , Dec. 1, 2015  Booth #3506 – Claymount is ... the annual meeting of the Radiological Society of ... this year. Based in the Netherlands ... Varian Medical Systems (NYSE: VAR ) and is one ... chambers and solid state automatic exposure control systems for controlling ...
Breaking Medicine Technology: